A Słomka, M Kowalewski, E Żekanowska - Pathogens, 2020 - mdpi.com
Infection with severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the …
L Sabioni, A De Lorenzo, C Lamas, F Muccillo… - Microvascular …, 2021 - Elsevier
Background Microvascular dysfunction, serum cytokines and chemokines may play important roles in pathophysiology of coronavirus disease 2019 (COVID-19), especially in …
NGM Attallah, AH El-Kadem, WA Negm, E Elekhnawy… - Pharmaceuticals, 2021 - mdpi.com
The global emergence of the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has focused the entire world's attention toward …
M Park, M Hur, H Kim, CH Lee, JH Lee… - Annals of …, 2022 - synapse.koreamed.org
Background Biomarkers and clinical indices have been investigated for predicting mortality in patients with coronavirus disease (COVID-19). We explored the prognostic utility of …
SN Lin, J Rui, QP Chen, B Zhao, SS Yu, ZY Li… - Infectious diseases of …, 2021 - Springer
Background Novel coronavirus disease 2019 (COVID-19) causes an immense disease burden. Although public health countermeasures effectively controlled the epidemic in …
W Liu, Z Guo, B Abudunaibi, X Ouyang… - Frontiers in public …, 2022 - frontiersin.org
Background In September 2021, there was an outbreak of coronavirus disease 2019 (COVID-19) in Xiamen, China. Various non-pharmacological interventions (NPIs) and …
Clinical trial endpoints must be carefully and intentionally selected so that the results of the trial can be used to inform policy-and decision-making. The relative importance of potential …
I Zahradka, V Petr, K Jakubov, I Modos, F Hruby… - Frontiers in …, 2023 - frontiersin.org
Introduction There is a strong impetus for the use of telemedicine for boosting early detection rates and enabling early treatment and remote monitoring of COVID-19 cases, particularly in …